Introduction Few potentially curative treatment options exist besides resection for patients with very large (>= 10 cm) hepatocellular carcinoma ( HCC). We sought to examine the outcomes and risk factors for recurrence after resection of >= 10 cm HCC. Methods Perioperative and long-term outcomes were examined for 189 consecutive patients from 1993 to 2004 who underwent potentially curative resection of HCC >= 10 cm ( n= 24; 13%) vs. those with HCC < 10 cm ( n= 165; 87%). Disease-free survival (DFS) and overall survival ( OS) were determined by Kaplan-Meier analysis and patient, tumor, and treatment characteristics were compared using univariate and multivariate analysis. Results Median follow-up was 34 months. Tumors >= 10 cm were more likely to be symptomatic, of poorer grade, and have vascular invasion ( p < 0.05). Twelve patients (50%) underwent an extended resection of more than four hepatic segments or resection of adjacent organs for oncologic clearance (diaphragm-2, inferior vena cava (IVC)-2, median sternotomy-1). Postoperative complications were more common after resection of > 10 cm HCC (12/24, 50% vs. 35/165, 21%; p= 0.04). Median DFS was significantly shorter in patients with large HCC (>= 10 cm) group compared to patients with smaller HCC (8.4 vs. 38 months; p= 0.001), but overall survival was not different between the two groups (5-year survival 54% vs. 53%; p= 0.43). Seventeen patients (71%) with very large HCC developed recurrences ( 12 intrahepatic, five systemic); eight of these patients (47%) underwent additional therapy (resection-4, TACE-3, RFA-1). Pathological positive margins and vascular invasion were significant determinants of DFS in tumors >= 10 cm ( p < 0.05), but only vascular invasion was an independent risk factor for recurrence after multivariate analysis ( HR 0.17; 95% CI: 0.04 - 0.8). Median OS after recurrence was 24 months. Conclusion Surgical resection is the optimal therapy for very large (>= 10 cm) HCC. Although recurrences are common after resection of these tumors, overall survival was not significantly different from patients after resection of smaller HCC in this series.
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Fong, YM
;
Sun, RL
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Sun, RL
;
Jarnagin, W
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Jarnagin, W
;
Blumgart, LH
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Fong, YM
;
Sun, RL
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Sun, RL
;
Jarnagin, W
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA
Jarnagin, W
;
Blumgart, LH
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Surg Serv, New York, NY 10021 USA